These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3679569)

  • 1. Profile of the uremic neutrophil.
    Schwebke JR; Mujais SK
    Int J Artif Organs; 1987 Sep; 10(5):287-90. PubMed ID: 3679569
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte activation during hemodialysis: a chemiluminescence study.
    Mori R; Triolo L; Ceriati F; Lippa S; Oradei A; De Sole P
    Life Support Syst; 1983; 1 Suppl 1():154-7. PubMed ID: 6336399
    [No Abstract]   [Full Text] [Related]  

  • 3. Restorative effect of ofloxacin on inhibited chemiluminescence response of PMNs by sera from uraemic patients.
    Matsumoto T; Takahashi K; Sakumoto M; Kumazawa J
    Drugs; 1995; 49 Suppl 2():289-90. PubMed ID: 8549335
    [No Abstract]   [Full Text] [Related]  

  • 4. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
    Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysfunction in uremia.
    Cohen G; Haag-Weber M; Hörl WH
    Kidney Int Suppl; 1997 Nov; 62():S79-82. PubMed ID: 9350688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute effect of hemodialysis on neutrophil migration: impact on humoral and cellular function.
    Pedersen JO; Knudsen F; Jersild C
    Kidney Int Suppl; 1988 Mar; 24():S86-9. PubMed ID: 3163061
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of malnutrition and uremia on impaired cellular host defence.
    Haag-Weber M; Dumann H; Hörl WH
    Miner Electrolyte Metab; 1992; 18(2-5):174-85. PubMed ID: 1465054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system in uremia and during its treatment.
    Haag-Weber M; Hörl WH
    New Horiz; 1995 Nov; 3(4):669-79. PubMed ID: 8574597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study of neutrophil leukocyte function in uremic patients and renal transplant recipients.
    Lee CJ; Lee PH; Lee PC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):138-45. PubMed ID: 6391852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodialysis and the regulation of immunologic response in chronic uremia].
    Luciak M
    Pol Arch Med Wewn; 1989 Feb; 81(2):65-9. PubMed ID: 2616358
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P; Bozkurt F
    Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis.
    Jaber BL; Balakrishnan VS; Cendoroglo MN; Perianayagam MC; King AJ; Pereira BJ
    Blood Purif; 1998; 16(6):325-35. PubMed ID: 10343079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular acidification enhances neutrophil phagocytosis in chronic haemodialysis patients: possible role of CD11b/CD18.
    Lin CS; Wann JG; Hsiao CW; Tai DW; Chen JS; Hsu YH; Huang HC; Chao CF
    Nephrol Dial Transplant; 2008 May; 23(5):1642-9. PubMed ID: 18065787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor alveolar macrophages in experimentally induced uremia.
    Alevy YG; Hutcheson P; Mueller KR; Slavin RG
    J Reticuloendothel Soc; 1983 Jan; 33(1):11-20. PubMed ID: 6572723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studying the immune reactivity of uremic patients by phytohemagglutinin-stimulated lymphocyte culture].
    Petri I; Gál G; Kaiser G; Maráz A
    Orv Hetil; 1974 Mar; 115(11):613-5. PubMed ID: 4815461
    [No Abstract]   [Full Text] [Related]  

  • 19. Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance.
    Krawczyk W; Marczewski K; Ledwozyw A
    Clin Nephrol; 1995 Nov; 44(5):340. PubMed ID: 8605718
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.